Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ.

Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9.

2.

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

Mamounas EP, Jeong JH, Wickerham DL, Smith RE, Ganz PA, Land SR, Eisen A, Fehrenbacher L, Farrar WB, Atkins JN, Pajon ER, Vogel VG, Kroener JF, Hutchins LF, Robidoux A, Hoehn JL, Ingle JN, Geyer CE Jr, Costantino JP, Wolmark N.

J Clin Oncol. 2008 Apr 20;26(12):1965-71. doi: 10.1200/JCO.2007.14.0228. Epub 2008 Mar 10.

PMID:
18332472
3.

A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.

Berkenblit A, Matulonis UA, Kroener JF, Dezube BJ, Lam GN, Cuasay LC, BrĂ¼nner N, Jones TR, Silverman MH, Gold MA.

Gynecol Oncol. 2005 Oct;99(1):50-7.

PMID:
16023182
4.

Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma.

Elias DJ, Hirschowitz L, Kline LE, Kroener JF, Dillman RO, Walker LE, Robb JA, Timms RM.

Cancer Res. 1990 Jul 1;50(13):4154-9.

5.

Acute myelofibrosis. Treatment with allogeneic bone marrow transplantation.

Kroener JF, McMillan R, Beutler E.

JAMA. 1983 Mar 4;249(9):1189-90. No abstract available.

PMID:
6337287
6.

5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.

Kroener JF, Saleh F, Howell SB.

Cancer Treat Rep. 1982 May;66(5):1133-7.

PMID:
7083215

Supplemental Content

Loading ...
Support Center